PHO |
Paediatric haemato-oncology |
HCT |
Haematopoietic cell transplantation |
EUCAST |
European Committee on Antimicrobial Susceptibility Testing |
SI |
Staphylococcal infection |
S. |
Staphylococcus |
MRSA |
Methicillin-resistant Staphylococcus aureus
|
MRSE |
Methicillin-resistant Staphylococcus epidermidis
|
MRCNS |
Methicillin-resistant coagulase-negative Staphylococcus
|
CoNS |
Coagulase-negative Staphylococcus
|
OR |
Odds ratio |
HR |
Hazard ratio |
CI |
Confidence interval |
ALL |
Acute lymphoblastic leukaemia |
AML |
Acute myeloid leukaemia |
NHL |
Non-Hodgkin lymphoma |
HD |
Hodgkin disease |
MDS |
Myelodysplastic syndrome |
CML |
Chronic myeloid leukaemia |
LCH |
Langerhans cell histiocytosis |
CNST |
Central nervous system tumour |
NBL |
Neuroblastoma |
WT |
Wilms tumour |
ES |
Ewing sarcoma |
OS |
Osteosarcoma |
RMS |
Rhabdomyosarcoma |
GCT |
Germ cell tumour |
SAA |
Severe aplastic anaemia |
PID |
Primary immunodeficiency |
SHR |
Subdistribution hazard ratio |
CVC |
Central venous catheter |
ALT |
Antibiotic lock therapy |
GvHD |
Graft-versus-host disease |
PBP2a |
Penicillin-binding protein 2a |
WGS |
Whole genome sequencing |